AMRYT PHARMA PLC - SPNR ADR (AMYT) Stock Price & Overview

NASDAQ:AMYTUS03217L1061

Current stock price

14.7 USD
+0.01 (+0.07%)
At close:
14.7 USD
0 (0%)
After Hours:

The current stock price of AMYT is 14.7 USD. Today AMYT is up by 0.07%. In the past month the price increased by 1.03%. In the past year, price increased by 86.55%.

AMYT Key Statistics

52-Week Range6.41 - 14.77
Current AMYT stock price positioned within its 52-week range.
1-Month Range14.52 - 14.76
Current AMYT stock price positioned within its 1-month range.
Market Cap
2.637B
P/E
N/A
Fwd P/E
N/A
EPS (TTM)
N/A
Dividend Yield
N/A

AMYT Stock Performance

Today
+0.07%
1 Week
+0.62%
1 Month
+1.03%
3 Months
-0.14%
Longer-term
6 Months +116.18%
1 Year +86.55%
2 Years N/A
3 Years N/A
5 Years N/A
10 Years N/A

AMYT Stock Chart

AMRYT PHARMA PLC - SPNR ADR / AMYT Daily stock chart

AMYT Technical Analysis

ChartMill assigns a technical rating of 7 / 10 to AMYT. When comparing the yearly performance of all stocks, AMYT is one of the better performing stocks in the market, outperforming 96.95% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

AMYT Earnings

Next Earnings DateN/A
Last Earnings DateMar 3, 2022
PeriodQ3 / 2021
EPS Reported-$0.07
Revenue Reported
EPS Surprise %
Revenue Surprise 9.46%

AMYT Forecast & Estimates

7 analysts have analysed AMYT and the average price target is 36.48 USD. This implies a price increase of 148.2% is expected in the next year compared to the current price of 14.7.


Analysts
Analysts82.86
Price Target36.48 (148.16%)
EPS Next YN/A
Revenue Next YearN/A

AMYT Financial Highlights


Income Statements
Revenue(TTM)N/A
Net Income(TTM)-87.53M
Industry RankSector Rank
PM (TTM) N/A
ROA N/A
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%N/A
Sales Q2Q%N/A
EPS 1Y (TTM)N/A
Revenue 1Y (TTM)N/A

AMYT Ownership

Ownership
Inst OwnersN/A
Shares179.38M
Float0
Ins OwnersN/A
Short Float %N/A
Short RatioN/A

About AMYT

Company Profile

AMYT logo image Amryt Pharma Plc is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. The firm is focused on developing and commercialization of treatments for orphan and rare diseases patients. The Company’s commercial business provides orphan disease products, which includes Juxtapid/ Lojuxta and Myalept / Myalepta. The Company’s lead development candidate is FILSUVEZ.

Company Info

IPO: 2007-04-27

AMRYT PHARMA PLC - SPNR ADR

Ivybridge House, 1 Adam Street

London D02 CR98 GB

CEO: Dr. Joseph A. Wiley

Employees: 99

AMYT Company Website

Phone: 442034155730.0

AMRYT PHARMA PLC - SPNR ADR / AMYT FAQ

What does AMRYT PHARMA PLC - SPNR ADR do?

Amryt Pharma Plc is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. The firm is focused on developing and commercialization of treatments for orphan and rare diseases patients. The Company’s commercial business provides orphan disease products, which includes Juxtapid/ Lojuxta and Myalept / Myalepta. The Company’s lead development candidate is FILSUVEZ.


Can you provide the latest stock price for AMRYT PHARMA PLC - SPNR ADR?

The current stock price of AMYT is 14.7 USD. The price increased by 0.07% in the last trading session.


What is the dividend status of AMRYT PHARMA PLC - SPNR ADR?

AMYT does not pay a dividend.


What is the ChartMill technical and fundamental rating of AMYT stock?

AMYT has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 0 out of 10.


On which exchange is AMYT stock listed?

AMYT stock is listed on the Nasdaq exchange.


What sector and industry does AMRYT PHARMA PLC - SPNR ADR belong to?

AMRYT PHARMA PLC - SPNR ADR (AMYT) operates in the Health Care sector and the Pharmaceuticals industry.